Home > Back to Publisher > Report Information

NBJ Integrative Medicine Report

Nutrition Business Journal
March 1, 2009
175 Pages - SKU: NUT2273739

Abstract Table of Contents Search inside this report Related Reports

Countries covered: United States

With a new administration and political party in power, the time for true healthcare reform appears to be more than just a dream in the United States, where millions of people are uninsured and nutrition©\related chronic diseases are ravaging whole swaths of the population. Integrative therapies, including dietary supplement usage, are poised to benefit as a result of the growing push in the United States for a healthcare system that focuses on disease prevention rather than disease treatment.

Recently, a perfect storm of factors has created conditions that have given rise to a national coalescence around the need for the kind of care that integrative medicine delivers. Those factors include out©\of©\control healthcare costs; rising rates of obesity, diabetes and other preventable health problems; a new Democratic administration and Congress poised to change the nation¡¯s healthcare landscape; and increasing acceptance among consumers, doctors and hospitals that integrating the best of conventional and complementary therapies produces tangible benefits, ranging from preventive care to improved patient outcomes to savings on the bottom line.

These and others forces are pushing integrative medicine proponents to forge alliances, not only among practitioners and researchers, but also among large employers, academic institutions, insurers, legislators, healthcare reform advocates and public interest groups. Their goal has evolved far beyond merely promoting integrative medicine practices, such as acupuncture or dietary supplement usage. Instead, this national coalition seeks to reform the bedrock of America¡¯s healthcare system itself by focusing on disease prevention and bringing together allopathic and alternative forms of care.

As Ralph Snyderman, MD, chancellor emeritus for health affairs at Duke University and a physician advisor for the Bravewell Collaborative, stressed during a recent interview with Nutrition Business Journal, the need for such reform is dire. ¡°Despite spending more than any other country on healthcare¡ª$2.3 trillion a year¡ª47 million Americans are uninsured, and those who are insured often don¡¯t have access to any type of coherent, coordinated way to maintain their health,¡± Snyderman said. ¡°Even with individuals who are well insured, when an event occurs, they realize how uncoordinated and uncaring the system is. This is the American healthcare dilemma.¡±

1. EXECUTIVE SUMMARY
2. ACKNOWLEDGEMENTS & DEFINITIONS: 2.1. ACKNOWLEDGEMENTS; 2.2. RESEARCH METHODOLOGY; 2.3. DEFINITIONS
3. MARKET DATA & OVERVIEW: 3.1. U.S. NUTRITION & SUPPLEMENT INDUSTRY
4. U.S. HEALTHCARE INDUSTRY: 4.1. HEALTH CARE EXPENDITURES
5. U.S. INTEGRATIVE MEDICINE MARKET: 5.1. PRACTITIONER POPULATION; 5.1. SUPPLEMENT SALES; 5.2. THERAPY/SERVICE REVENUES; 5.3. GROWTH & TRENDS
6. INTEGRATIVE MEDICINE MODALITIES: 6.1. ACUPUNCTURE; 6.2. AYURVEDA; 6.3. CHIROPRACTIC; 6.4. HOMEOPATHY; 6.5. MASSAGE THERAPY; 6.6. NATUROPATHY; 6.7. NURSES/MDS; 6.8. OSTEOPATHY; 6.9. TRADITIONAL CHINESE MEDICINE
7. CONDITION SPECIFIC MARKETS: 7.1. CONDITION SPECIFIC SUPPLEMENT OVERVIEW; 7.2. GENERAL HEALTH; 7.3. COLD/FLU-IMMUNE; 7.4. SPORTS/ENERGY/WEIGHT-LOSS; 7.5. BRAIN/MENTAL ACUITY; 7.6. INSOMNIA; 7.7. MOOD/DEPRESSION; 7.8. MENOPAUSE; 7.9. CARDIO/HEART HEALTH; 7.10. JOINT HEALTH; 7.11. SEXUAL HEALTH; 7.12. BONE HEALTH; 7.13. GASTROINTESTINAL HEALTH; 7.14. DIABETES; 7.15. CANCER PREVENTION
8. CONSUMERS & INTEGRATIVE MEDICINE: 8.1. CONSUMER SUPPLEMENT USAGE & SPENDING; 8.2. CHILDREN’S CAM SUPPLEMENT USAGE; 8.3. TOP SUPPLEMENTS USED BY ADULTS VIA PRACTITIONERS
9. PRACTITIONER CHANNEL: 9.1. PRACTITIONER SALES CHANNEL OVERVIEW; 9.2. U.S. PRACTITIONER SUPPLEMENT SALES FORECAST 2008-2018E
10. Q&A WITH INTGRATIVE MEDICINE THOUGHT LEADERS: 10.1. NATIONAL CENTER FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE DIRECTOR JOSEPHINE BRIGGS, MD; 10.2. SCRIPPS CENTER FOR INTEGRATIVE MEDICINE FOUNDER ERMINIA “MIMI” GUARNERI, MD, FACC; 10.3. JEFFREY BLAND, PHD, CHIEF SCIENCE OFFICER OF METAGENICS
11. COMPANY PROFILES: 11.1. ALLERGY RESEARCH (KI NUTRICARE); 11.2. ATRIUM INNOVATIONS (DOUGLAS LABS); 11.3. DESIGNS FOR HEALTH; 11.4. EMERSON ECOLOGICS, INC.; 11.5. INTEGRATIVE THERAPEUTICS (ENZYMATIC THERAPY); 11.6. METAGENICS; 11.7. NORDIC NATURALS; 11.8. PROGRESSIVE LABORATORIES, INC.; 11.9. SEROYAL; 11.10. STANDARD PROCESS; 11.11. THORNE RESEARCH, INC.; 11.12. XYMOGEN, INC.
INDEX OF FIGURES: Figure 3-4 U.S. Practitioner Supplement Sales Growth by Modality in 2008; Figure 3-1 U.S. Nutrition Industry Revenues, 2007; Figure 3-2 U.S. Nutrition Industry by Product Sales, 2000-2007; Figure 3-3 U.S. Nutrition Industry by Product Growth, 2000-2007; Figure 3-4 U.S. Supplement and Nutrition Industry Sales Growth by Product, 2007; Figure 3-5 U.S. Nutrition Industry by Product Sales, 2008e-2017e; Figure 3-6 U.S. Nutrition Industry by Product Growth, 2008e-2017e; Figure 3-7 U.S. Nutrition Industry Sales & Annual Growth, 2000-2017e; Figure 3-8 U.S. Supplement vs. Total Nutrition Industry Annual Sales Growth, 2000-2017e; Figure 4-1 U.S. Health Care Expenditures 2001-2007; Figure 5-1 U.S. Integrative Medicine Licensed, Lay, Student & Part-Time Practitioner Population and Growth; 1999-2007; Figure 5-2 U.S. Integrative Medicine Licensed, Lay, Student & Part-Time Practitioner Population 1999-2007; Figure 5-3 U.S. Integrative Medicine Supplement Sales 1999-2018e; Figure 5-4 U.S. Integrative Medicine Supplement Sales 1999-2018e; Figure 5-5 U.S. Integrative Medicine Therapy/Service Revenues 1999-2018e; Figure 5-6 U.S. Integrative Medicine Therapy/Service Revenues 1999-2018e; Figure 6-1 U.S. Acupuncture Professional Population 1999-2018e; Figure 6-2 U.S. Acupuncturist Population & Growth 1999-2018e; Figure 6-3 U.S. Acupuncturist Supplement Sales 1999-2018e; Figure 6-4 U.S. Acupuncturist Supplement Sales & Growth 1999-2018e; Figure 6-5 U.S. Acupuncturist Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008; Figure 6-6 U.S. Acupuncture Therapy/Service Revenues & Growth 1999-2018e; Figure 6-7 U.S. Acupuncturist Therapy/Service Revenues & Growth 1999-2018e; Figure 6-8 U.S. Ayurvedic Practitioner Population 1999-2018e; Figure 6-9 U.S. Ayurvedic Pracitioner Population & Growth 1999-2018e; Figure 6-10 U.S. Ayurvedic Supplement Sales 1999-2018e; Figure 6-11 U.S. Ayurvedic Supplement Sales & Growth 1999-2018e; Figure 6-12 U.S. Ayurvedic Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008 ... 62; Figure 6-13 U.S. Ayurvedic Therapy/Service Revenues & Growth 1999-2018e; Figure 6-14 U.S. Acupuncturist Therapy/Service Revenues & Growth 1999-2018e; Figure 6-15 U.S. Chiropractic Professional Population 1999-2018e; Figure 6-16 U.S. Chiropractic Practitioner Population & Growth 1999-2018e; Figure 6-17 U.S. Chiropractic Supplement Sales 1999-2018e; Figure 6-18 U.S. Chiropractic Supplement Sales & Growth 1999-2018e; Figure 6-19 U.S. Chiropractic Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008 66; Figure 6-20 U.S. Chiropractic Therapy/Service Revenues & Growth 1999-2018e; Figure 6-21 U.S. Chiropractic Therapy/Service Revenues & Growth 1999-2018e; Figure 6-22 U.S. Homeopathic Professional Population 1999-2018e; Figure 6-23 U.S. Homeopathic Practitioner Population & Growth 1999-2018e; Figure 6-24 U.S. Homeopathic Supplement Sales 1999-2018e; Figure 6-25 U.S. Homeopathic Supplement Sales & Growth 1999-2018e; Figure 6-26 U.S. Homeopathic Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008; Figure 6-27 U.S. Chiropractic Therapy/Service Revenues & Growth 1999-2018e; Figure 6-28 U.S. Homeopathic Therapy/Service Revenues & Growth 1999-2018e; Figure 6-29 U.S. Massage Therapy Professional Population 1999-2018e; Figure 6-30 U.S. Massage Therapy Practitioner Population & Growth 1999-2018e; Figure 6-31 U.S. Massage Therapy Supplement Sales 1999-2018e; Figure 6-32 U.S. Massage Therapy Supplement Sales & Growth 1999-2018e; Figure 6-33 U.S. Massage Therapy Supplement Sales as a Percentage of Total Practitioner Supplement Sales in; 2008; Figure 6-34 U.S. Massage Therapy/Service Revenues & Growth 1999-2018e; Figure 6-35 U.S. Massage Therapy/Service Revenues & Growth 1999-2018e; Figure 6-36 U.S. Naturopathy Professional Population 1999-2018e; Figure 6-37 U.S. Naturopathy Practitioner Population & Growth 1999-2018e; Figure 6-38 U.S. Naturopathic Supplement Sales 1999-2018e; Figure 6-39 U.S. Naturopathic Supplement Sales & Growth 1999-2018e; Figure 6-40 U.S. Naturopathy Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008; Figure 6-41 U.S. Naturopathy Therapy/Service Revenues & Growth 1999-2018e; Figure 6-42 U.S. Naturopathy Therapy/Service Revenues & Growth 1999-2018e; Figure 6-43 U.S. Nurses & MDs Professional Population 1999-2018e; Figure 6-44 U.S. Nurses/MD Practitioner Population & Growth 1999-2018e; Figure 6-45 U.S. Nurses/MDs Supplement Sales 1999-2018e; Figure 6-46 U.S. Nurse/MD Supplement Sales & Growth 1999-2018e; Figure 6-47 U.S. Nurse/MD Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008 .. 82; Figure 6-48 U.S. Nurses/MDs Therapy/Service Revenues & Growth 1999-2018e; Figure 6-49 U.S. Nurse/MD Therapy/Service Revenues & Growth 1999-2018e; Figure 6-50 U.S. Osteopath Professional Population 1999-2018e; Figure 6-51 U.S. Osteopathic Practitioner Population & Growth 1999-2018e; Figure 6-52 U.S. Osteopath Supplement Sales 1999-2018e; Figure 6-53 Osteopath Supplement Sales & Growth 1999-2018e; Figure 6-54 U.S. Osteopath Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008 .. 86; Figure 6-55 U.S. Osteopathic Therapy/Service Revenues & Growth 1999-2018e; Figure 6-56 U.S. Osteopathic Therapy/Service Revenues & Growth 1999-2018e; Figure 6-57 U.S. Traditional Chinese Medicine Professional Population 1999-2018e; Figure 6-58 U.S. Traditional Chinese Medicine Practitioner Population & Growth 1999-2018e; Figure 6-59 U.S. Traditional Chinese Medicine Supplement Sales & Growth 1999-2018e; Figure 6-60 Traditional Chinese Medicine Supplement Sales & Growth 1999-2018e; Figure 6-61 U.S. TCM Supplement Sales as a Percentage of Total Practitioner Supplement Sales in 2008; Figure 6-62 U.S. Traditional Chinese Medicine Therapy/Service Revenues & Growth 1999-2018e; Figure 6-63 U.S. Traditional Chinese Medicine Therapy/Service Revenues & Growth 1999-2018e; Figure 7-1 U.S. Sales of Condition Specific Supplements, OTC, Rx in 2007; Figure 7-2 U.S. Condition Specific Supplement Markets & Annual Growth 1999-2017e; Figure 7-3 U.S. Condition Specific Supplement, OTC, Rx Sales 1998-2007; Figure 7-4 U.S. Condition Specific Supplement, OTC, Rx Growth, 2000-2007; Figure 7-5 U.S. Condition Specific OTC Markets Sales 2004-2007; Figure 7-6 U.S. Condition Specific Rx Sales 2004-2007; Figure 7-7 U.S. General Health Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-8 U.S. Condition Specific General Health Markets Sales 1999-2007; Figure 7-9 NBJ’s Top General Health Supplements in 2007; Figure 7-10 U.S. General Health Condition Specific Supplement Sales 1999-2007; Figure 7-11 U.S. Cold/Flu-Immune Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-12 U.S. Immune Health Markets Sales 1999-2017e; Figure 7-13 NBJ’s Top Immune Health Supplements in 2007; Figure 7-14 U.S. Immune Health Condition Specific Supplement Sales 1999-2007; Figure 7-15 U.S. Sports/Energy/Weight-Loss Condition Specific Supplement Sales and Growth 1999-2017e .... 108; Figure 7-16 U.S. Sports/Energy/Weight-Loss Markets Sales 1999-2017e; Figure 7-17 NBJ’s Top Sports/Energy/Weight-Loss Supplements in 2007; Figure 7-18 NBJ’s Top Sports/Energy/Weight-Loss Condition Specific Supplement Sales 1999-2007; Figure 7-19 U.S. Brain/Mental Acuity Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-20 U.S. Brain/Mental Acuity Condition Specific Markets Sales 1999-2017e; Figure 7-21 NBJ’s Top Brain/Mental Acuity Condition Specific Supplements in 2007; Figure 7-22 U.S. Brain/Mental Acuity Supplement Sales 1999-2007; Figure 7-23 U.S. Insomnia Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-24 U.S. Insomnia Condition Specific Markets Sales 1999-2017e; Figure 7-25 NBJ’s Top Insomnia Condition Specific Supplements in 2007; Figure 7-26 U.S. Insomnia Condition Specific Supplement Sales 1999-2007; Figure 7-27 U.S. Mood/Depression Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-28 U.S. Mood/Depression Condition Specific Markets Sales 1999-2017e; Figure 7-29 NBJ’s Top Mood/Depression Condition Specific Supplements in 2007; Figure 7-30 U.S. Mood/Depression Condition Specific Supplement Sales 1999-2007; Figure 7-31 U.S. Menopause Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-32 U.S. Menopause Condition Specific Markets Sales 1999-2017e; Figure 7-33 NBJ’s Top Menopause Condition Specific Supplements in 2007; Figure 7-34 U.S. Menopause Condition Specific Supplement Sales 1999-2007; Figure 7-35 U.S. Cardio/Heart Health Condition Specific Markets Sales 1999-2007; Figure 7-36 NBJ’s Top Cardio/Hearth Health Supplements in 2007; Figure 7-37 U.S. Cardio/Heart Health Condition Specific Supplement Sales 1999-2007; Figure 7-38 U.S. Joint Health Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-39 U.S. Joint Health Condition Specific Markets Sales 1999-2007; Figure 7-40 NBJ’s Top Joint Health Condition Specific Supplements in 2007; Figure 7-41 U.S. Joint Health Condition Specific Supplement Sales 1999-2007; Figure 7-42 U.S. Sexual Health Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-43 U.S. Sexual Health Condition Specific Markets Sales 1999-2017e; Figure 7-44 NBJ’s Sexual Health Condition Specific Supplements in 2007; Figure 7-45 U.S. Sexual Health Condition Specific Supplement Sales 1999-2007; Figure 7-46 U.S. Bone Health Condition Specific Supplement Sales and Growth 1999-2007; Figure 7-47 U.S. Bone Health Condition Specific Markets Sales 1999-2017e; Figure 7-48 NBJ’s Bone Health Condition Specific Supplements in 2007; Figure 7-49 U.S. Bone Condition Specific Supplement Sales 1999-2007; Figure 7-50 U.S. Gastrointestinal Health Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-51 U.S. Gastrointestinal Health Condition Specific Markets Sales 1999-2017e; Figure 7-52 NBJ’s Gastrointestinal Health Condition Specific Supplements in 2007; Figure 7-53 U.S. Gastrointestinal Health Condition Specific Supplement Sales 1999-2007; Figure 7-54 U.S. Diabetes Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-55 U.S. Diabetes Condition Specific Markets Sales 1999-2017e; Figure 7-56 NBJ’s Top Diabetes Condition Specific Supplements in 2007; Figure 7-57 U.S. Diabetes Condition Specific Supplement Sales 1999-2007; Figure 7-58 U.S. Cancer Prevention Condition Specific Supplement Sales and Growth 1999-2017e; Figure 7-59 U.S. Cancer Prevention Condition Specific Markets Sales 1999-2017e; Figure 7-60 NBJ’s Cancer Prevention Condition Specific Supplements in 2007; Figure 7-61 U.S. Cancer Prevention Condition Specific Supplement Sales 1999-2007; Figure 8-1 U.S. Consumer Total Supplement Use Summary, 2007; Figure 8-2 U.S. Consumer Total Supplement Use as % of Market, 1999-2007; Figure 8-3 U.S. Consumer Total Supplement Use: Number of Users, 1999-2007; Figure 8-4 Supplements Users & Non-Users, 2007; Figure 8-5 Frequencies and age-adjusted percents of children under 18 years of age who used selected types of; nonvitamin, nonmineral, natural products, for health reasons in the past 30 days, by type of product used:; United States, 2007; Figure 8-6 Frequencies and age-adjusted percents of adults 18 years and over who used selected types of; nonvitamin, nonmineral, natural products, for health reasons in the past 30 days, by type of product used:; United States, 2007; Figure 9-1 U.S. Nutrition Industry Practitioner Channel Sales by Product, 2007; Figure 9-2 U.S. Practitioner Supplement Sales & Annual Growth 1997-2007; Figure 9-3 U.S. Nutrition Industry Sales by Channel, 1998-2007; Figure 9-4 U.S. Supplement Sales by Channel, 1998-2007; Figure 9-5 U.S. Practitioner Supplement Sales Growth vs. Total Supplement Growth, 1997-2007; Figure 9-6 U.S. Supplement Sales by Channel in 2007; Figure 9-7 U.S. Practitioner Nutrition Industry Sales by Product in 2007; Figure 9-8 U.S. Practitioner Supplement Sales by Product, 2000-2007; Figure 9-9 U.S. Practitioner Supplement Sales Growth 1998-2007; Figure 9-10 U.S. All Channels Supplement Sales Growth 1998-2007; Figure 9-11 U.S. Practitioner Supplement Sales & Annual Growth Forecast 2008-2018e; Figure 9-12 U.S. Practitioner Supplement Sales & Growth vs. Total Supplement Market, 2008-2017; Figure 9-13 U.S. Practitioner Supplement Sales Growth vs. All Channel Supplement Growth, 1990-2017

More United States Therapeutic Area Reports

United States Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters by GlobalData
United States Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters Summary GlobalData’s new report, “United States Nephrology and Urology ...

North America Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters by GlobalData
North America Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters Summary GlobalData’s new report, “North America Nephrology and Urology ...

2012 US Tumor Marker Testing Market Outlook: Growth Opportunities and Strategies by Venture Planning Group
Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social ...

The Market for Home Care Products, 7th Edition by Kalorama Information
This report, The Market for Home Care Products, 7th. Edition covers the market for products specially designed to assist with regular tasks of daily living. ...

NRT Smoking Cessation Aids in the US by Euromonitor International
The number of smokers in the US continued to decline, falling another 0.3% in 2011 despite a growing population. For those looking to quit, NRT ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

NBJ Integrative Medicine Report

Share this report

Other tasks

Research Assistance

Related Markets

Therapeutic Area Reports

Free Alert Me service